Location History:
- Bellevue, WA (US) (2012)
- New York, NY (US) (2021)
- Ithaca, NY (US) (2024)
Company Filing History:
2 out of 2,886 
1 out of 1,458 
1 out of 832,912 Years Active: 2012-2024
Title: Christopher E Mason: Innovator in Genetic Research
Introduction
Christopher E Mason is a prominent inventor based in Ithaca, NY (US). He has made significant contributions to the field of genetic research, holding a total of 3 patents. His work focuses on innovative methods for analyzing genetic material, which have implications for understanding various diseases.
Latest Patents
Mason's latest patents include groundbreaking technologies. One of his patents is titled "Single sperm gene expression and mutation analysis for prediction of diseases." This invention is directed to methods for typing and characterizing sperm. The technology employs a sequencing-based method for detecting and measuring RNA transcripts from single sperm cells. It also analyzes the sequencing data to predict male parent contributions to autism. Another notable patent is "Methods and kit for characterizing the modified base status of a transcriptome." This invention relates to a method of characterizing the modified base status of a transcriptome. It involves contacting a transcriptome with an antibody specific to modified bases, isolating RNA transcripts, and identifying those present in higher abundance. This method has applications in diagnosing diseases and determining treatment effects on modified base levels in RNA.
Career Highlights
Christopher E Mason has worked at Cornell University, where he has contributed to various research initiatives. His work at this esteemed institution has allowed him to explore innovative solutions in genetic research and development.
Collaborations
Mason has collaborated with notable colleagues, including Marc T Beck and Craig S Brown. These partnerships have further enhanced his research capabilities and expanded the impact of his inventions.
Conclusion
Christopher E Mason is a distinguished inventor whose work in genetic research has led to significant advancements in understanding disease prediction and diagnosis. His innovative patents reflect his commitment to improving health outcomes through scientific discovery.